arrow_up-blue blog branches consultations events facebook-icon facebook-icon2 factsheet forum-icon forum hands key link location lock mail measure menu_plus news pdf pdf2 phone policies publications related search share subjectguide twitter-icon word instagram-icon youtube-icon

NICE Advanced Breast Cancer (standing committee update): Addendum Consultation

Status: CLOSED
Published: 17 May 2017 01:00

NICE is consulting on the Addendum to the Advanced Breast Cancer Clinical Guidelines 

These guidelines

  • will update NICE guideline CG81 (published February 2009)
  • covers care and support for people with advanced (stage 4) breast cancer.
  • aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life.

Please note that NICE have also added a new recommendation on assessing oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status on disease recurrence. 

For further information or to provide feedback, please contact Caroline Rapu

For further information, please contact Caroline Rapu 

Page last updated - 28/06/2018